Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Centessa Pharmaceuticals PLC Sponsored ADR (CNTA) had Weighted-Average Shares Outstanding (Diluted) of 134.16M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-54.89M |
|
-- |
|
-- |
|
$53.79M |
|
$-53.79M |
|
$-0.94M |
|
$-54.73M |
|
$-54.73M |
|
$-54.89M |
|
$-54.89M |
|
$-54.89M |
|
$-54.89M |
|
$-53.79M |
|
$-53.28M |
|
134.16M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
134.16M |
$-0.41 |
|
$-0.41 |
|
| Balance Sheet Financials | |
$307.68M |
|
$0.89M |
|
$140.62M |
|
$448.30M |
|
$29.12M |
|
$109.82M |
|
$117.60M |
|
$146.73M |
|
$301.57M |
|
$301.57M |
|
$301.57M |
|
134.42M |
|
| Cash Flow Statement Financials | |
$-138.01M |
|
$-200.40M |
|
$8.13M |
|
$383.22M |
|
$50.81M |
|
$-332.41M |
|
$23.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.56 |
|
-- |
|
-- |
|
0.27 |
|
0.36 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-138.37M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-18.20% |
|
-18.20% |
|
-12.24% |
|
-13.34% |
|
$2.24 |
|
$-1.03 |
|
$-1.03 |
|